Extended Research Article
Adalimumab, etanercept, infliximab,certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation
Matt Stevenson
,
Rachel Archer
,
Jon Tosh
,
Emma Simpson
,
Emma Everson-Hock
,
John Stevens
et al.
-
Journal:
Health Technology Assessment Volume: 20, Issue: 35
-
Published:
4 May 2016